World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 14 September 2015
Main ID:  NCT02340442
Date of registration: 13/01/2015
Prospective Registration: No
Primary sponsor: Medical University of Vienna
Public title: DVA Risk Pregnancy
Scientific title: Retinal Vessel Analysis in Low Risk and High Risk Pregnant Women
Date of first enrolment: October 2013
Target sample size: 120
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02340442
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Austria
Contacts
Name:     Harald Zeisler, Prof. MD
Address: 
Telephone: 01/40400 - 2881
Email: harald.zeisler@meduniwien.ac.at
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- • Age >18 years

- Written informed consent

- Pregnancy at screening

- Normal ophthalmic findings, unless the investigator considers a finding
clinically irrelevant.

- Ametropy <= 3,5 Dpt.

For pregnant women with preeclampsia:

- Systolic BP =140 mmHg, or diastolic BP =90 mmHg on at least 2 occasions AND

- Proteinuria (=300 mg/day) after 20 weeks of gestation in preeclampsia

- Pregnant at the time of confirming diagnosis of preeclampsia

For pregnant women with obesity:

• Pre-pregnancy BMI =30 as assessed from medical history

According to the WHO BMI classification:

- Underweight (less than 18.5)

- normal weight (18.5-24.9)

- overweight (25-29.9)

- obese class I (30 -34.9)

- obese class II (35-39.9)

- obese class III (40 or more) For non-pregnant control subjects

- Age >18 years

- Written informed consent

- Not pregnant at screening

- Normal ophthalmic and medical findings, unless the investigator considers a
finding clinically irrelevant.

- Ametropy <= 3,5 Dpt.

Exclusion Criteria:

- Diabetes mellitus type I or II

- Renal failure requiring dialysis

- Cirrhosis of liver

- Collagenosis

- Vasculitis

- Paraproteinaemia

- Alcohol abuse

- Amyloidosis

- Clinical signs of polyneuropathy

- Any other clinical finding, unless the clinical investigator considers a finding to
be non clinically significant.



Age minimum: 18 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Pregnancy
High Risk Pregnancies
Intervention(s)
Other: DVA measurements
Other: Fundus photographs
Other: Obstetrical care parameters
Primary Outcome(s)
flicker-induced retinal vasodilatation [Time Frame: at inclusion, 3 Trimenon, post partum]
Secondary Outcome(s)
adverse pregnancy outcome [Time Frame: post partum]
Secondary ID(s)
OPHT-060513
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history